ROLIMUS 10MG TABLET

About

Rolimus 10mg Tablet contains Everolimus, an oral mammalian target of rapamycin (mTOR) inhibitor. This medication is used in the treatment of various advanced cancers and for the prevention of organ transplant rejection. In oncology, Everolimus works by inhibiting the mTOR pathway, a critical intracellular signaling pathway that regulates cell growth, proliferation, and angiogenesis. By blocking this pathway, Everolimus effectively slows down the growth and spread of cancer cells, making it a targeted therapy for specific tumor types.

Its mechanism of action helps to arrest the cell cycle and reduce tumor vascularization, contributing to its efficacy in managing advanced diseases. It is often used in patients whose disease has progressed on other therapies, offering a valuable treatment option to improve progression-free survival.

Uses

• Advanced renal cell carcinoma
• Pancreatic neuroendocrine tumors (PNET)
• Subependymal giant cell astrocytoma (SEGA)
• HR+, HER2- advanced breast cancer

Directions For Use

Take orally once daily, at the same time each day, with or without food. Swallow tablets whole.

Benefits

• Oral administration offers convenience.
• Targeted therapy for specific cancers.
• Can prolong progression-free survival.
• Effective in various advanced solid tumors.
• Part of established treatment regimens.
• May improve outcomes in specific patient populations.

Side Effects

• Stomatitis (mouth sores)
• Rash
• Fatigue
• Diarrhea
• Nausea
• Anorexia
• Hyperglycemia
• Hyperlipidemia
• Pneumonitis (non-infectious)
• Peripheral edema
• Myelosuppression (anemia, thrombocytopenia)
• Infections

Safety Measures

• Alcohol - Avoid or limit alcohol due to potential for increased gastrointestinal irritation and liver strain.
• Pregnancy - Contraindicated. Everolimus can cause fetal harm. Use effective contraception during treatment and for 8 weeks after the last dose.
• Breastfeeding - Contraindicated. It is unknown if everolimus is excreted in human milk; discontinue breastfeeding due to potential for serious adverse reactions.
• Liver - Use with caution in patients with hepatic impairment. Dose adjustments are necessary; monitor liver function closely.
• Kidney - Use with caution in patients with renal impairment. No specific dose adjustment for mild-moderate, but monitor closely.
• Lung - Monitor closely for signs of non-infectious pneumonitis, a common and potentially serious side effect.

Disclaimer

MedEHub is committed to delivering reliable, expert-reviewd information to help consumers make informed health decisions. However, the content provided on this website is for informational purposes only and is not intended to replace professional medical advice, diagnosis or treatment.

Always consult your doctor for any medical concerns, and discuss your questions about health conditions or medications with a qualified healthcare professional. Do not ignore or delay seeking professional medical advice based on information found on Med E Hub.

Our goal is to complement, not replace, the essential doctor-patient relationship.